中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [20]
山西煤炭化学研究所 [9]
武汉物理与数学研究所 [8]
上海药物研究所 [4]
西安光学精密机械研究... [3]
植物研究所 [3]
更多
采集方式
OAI收割 [76]
内容类型
期刊论文 [62]
专利 [10]
会议论文 [3]
成果 [1]
发表日期
2024 [4]
2022 [12]
2021 [5]
2020 [4]
2019 [2]
2018 [5]
更多
学科主题
Biodiversi... [1]
Cell Biolo... [1]
Chemistry,... [1]
Environmen... [1]
Plant Scie... [1]
天文学 [1]
更多
筛选
浏览/检索结果:
共76条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
作者升序
作者降序
The Overview and Trial Observations of AIMS
期刊论文
OAI收割
RESEARCH IN ASTRONOMY AND ASTROPHYSICS, 2025, 卷号: 25, 期号: 7
作者:
Deng, Yuanyong
;
Wang, Dongguang
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2025/07/14
Sun: infrared
methods: observational
instrumentation: spectrographs
Talaromyces sedimenticola
sp. nov., isolated from the Mariana Trench
期刊论文
OAI收割
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 2024, 卷号: 117, 期号: 1, 页码: 9
作者:
Zhou, Hongbo
;
Xu, Liting
;
Liu, Wenxian
;
Ta, Kaiwen
;
Wang, Xincun
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2024/04/19
Morphology
Novel species
Phylogeny
Talaromyces
Moderate permeability enhanced microbial community turnover and copper extraction during bioleaching of low-grade copper ores
期刊论文
OAI收割
SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 卷号: 954, 页码: 10
作者:
Liu, Wenxian
;
Sun, Jianxing
;
Ai, Chenbing
;
Zhang, Ruiyong
;
Cheng, Haina
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/12/20
Bioleaching
Low-grade copper ores
Microbial community
Permeability
Antithetical impacts of deleterious
LRP1B
mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials
期刊论文
OAI收割
SCIENCE CHINA-LIFE SCIENCES, 2024
作者:
Wang, Jinliang
;
Zhou, Wenyong
;
Xu, Yu
;
Duan, Jianchun
;
Zhou, Qiaoxia
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/11/20
non-squamous NSCLC
squamous NSCLC
LRP1B deleterious mutations
predictive biomarker
immune checkpoint inhibitor
一种高活性改性生物炭及其制备方法和土壤改良剂
专利
OAI收割
专利号: CN202411151021.3, 申请日期: 2024-01-01,
作者:
潘大为
;
王宁
;
王立仙
;
刘芳
;
李文杰
  |  
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2025/02/13
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
OAI收割
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
OAI收割
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
  |  
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
期刊论文
OAI收割
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wei, Jingwen
;
Xiang, Jing
;
Hao, Yue
;
Si, Jinfei
;
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2022/12/22
Anemia
Epidermal growth factor receptor
Epidermal growth factor receptor tyrosine kinase inhibitors
Non-small cell lung cancer
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
OAI收割
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
  |  
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase